<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01666886</url>
  </required_header>
  <id_info>
    <org_study_id>EC 12/30/243</org_study_id>
    <nct_id>NCT01666886</nct_id>
  </id_info>
  <brief_title>Efficacy of Additional Titration During Oral Appliance Treatment for Sleep-disordered Breathing.</brief_title>
  <official_title>Efficacy of Additional Titration During Oral Appliance Treatment for Sleep-disordered Breathing.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Antwerp</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Antwerp</source>
  <brief_summary>
    <textblock>
      In the protocol &quot;Predicting therapeutic outcome of mandibular advancement device treatment in&#xD;
      obstructive sleep apnea (PROMAD)&quot;, 100 patients with obstructive sleep apnea are included and&#xD;
      started MAD treatment at 75% of maximal protrusion. All patients underwent polysomnography&#xD;
      with MAD in situ to evaluate the effect of the MAD on severity of sleep apnea. If the results&#xD;
      of the polysomnography with MAD are unsuccessful (defined as a reduction in AHI with the MAD&#xD;
      in situ of less than 50% compared to baseline), the therapy needs to be adjusted. Finding the&#xD;
      most effective protrusion should be a weighted compromise between efficacy and side-effects&#xD;
      of MAD therapy.&#xD;
&#xD;
      In patients with insufficient results on the polysomnography with the MAD at 75% of maximal&#xD;
      protrusion, the MAD will be further adjusted until 90% of the maximal protrusion measured at&#xD;
      the follow-up visit after the polysomnography with the MAD. After habituation and adaptation&#xD;
      period but within 2 months after the first polysomnography with MAD, a new polysomnography&#xD;
      will be performed to assess the effect of the 90% protruded position.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2012</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Polysomnographic efficacy</measure>
    <time_frame>3 to 6 months after start of therapy</time_frame>
    <description>Polysomnographic re-evaluation of the severity of sleep apnea (apnea/hypopnea index).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <arm_group>
    <arm_group_label>Mandibular Advancement Device (MAD)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mandibular advancement during therapy with a mandibular advancement device (MAD) in 90% of maximal protrusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mandibular Advancement Device (MAD)</intervention_name>
    <arm_group_label>Mandibular Advancement Device (MAD)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  Body Mass Index (BMI) ≤ 35 kg/m²&#xD;
&#xD;
          -  OSAS, as defined by the American Academy of Sleep Medicine Task Force&#xD;
&#xD;
          -  apnea-hypopnea index (AHI) &lt; 50&#xD;
&#xD;
          -  incomplete elimination of apneas and/or hypopnea during therapy with mandibular&#xD;
             advancement device in 75% of maximal protrusion&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other sleep disorders (i.e. parasomnias)&#xD;
&#xD;
          -  Invasive upper airway surgery for sleep-disordered breathing&#xD;
&#xD;
          -  Known genetic disorders with craniofacial and/or upper airway malformations&#xD;
&#xD;
          -  Use of benzodiazepine and/or antidepressants&#xD;
&#xD;
          -  Known history of psychiatric disease&#xD;
&#xD;
          -  Known history of fibromyalgia and/or chronic fatigue syndrome&#xD;
&#xD;
          -  Dental contra-indications: functional restrictions of the temporomandibular joint,&#xD;
             insufficient dentition with pathological changes, insufficient retention for MAD use&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Antwerp University Hospital</name>
      <address>
        <city>Wilrijk</city>
        <state>Antwerp</state>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>August 14, 2012</study_first_submitted>
  <study_first_submitted_qc>August 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2012</study_first_posted>
  <last_update_submitted>January 15, 2021</last_update_submitted>
  <last_update_submitted_qc>January 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Antwerp</investigator_affiliation>
    <investigator_full_name>ethisch.comite@uza.be</investigator_full_name>
    <investigator_title>Ethics Committee Antwerp Univerity Hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

